Clinicopathologic Characterization of Prostatic Cancer in Dogs
Animals · 10.02.2024 · 14 (4) · 588
DOI: 10.3390/ani14040588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animals, online erschienen am 10.02.2024. Verfasst von Demitria M Vasilatis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, training fellowship NIH.
Abstract (Originalsprache)
Clinicopathologic data in dogs with prostate cancer (PCa) may aid in the differentiation between tumor types and subsequent treatment decisions; however, these data are often unreported. Demographic, clinicopathologic, cytologic, histologic and survival data from dogs with primary prostatic adenocarcinoma (PRAD) (n = 56) and primary prostatic transitional cell carcinoma (P-TCC) (n = 74) were acquired from a tertiary veterinary teaching hospital from 1992 to 2022. Red blood cell distribution width (RDW) to albumin ratio (RAR) was evaluated for diagnostic utility in differentiating between PRAD and P-TCC. Sections from PRAD tumors (n = 50) were stained for androgen receptor (AR) expression, and laboratory data were compared between AR positive (AR+) and AR negative (AR−) groups. RDW was increased in PRAD, while albumin was decreased (p < 0.05). P-TCC was associated with Melamed-Wolinska bodies (MWB) and necrosis on cytology (p < 0.05). RAR had acceptable diagnostic utility in the differentiation of PCa tumors (AUC = 0.7; p < 0.05). Survival rates and metastases were equivocal. AR+ and AR− PRAD tumors did not differ in clinicopathologic data or survival (p > 0.05). In conclusion, hypoalbuminemia was significantly associated with PRAD and decreased survival, while MWB and necrosis were significantly associated with P-TCC on cytology. These clinicopathologic data may help clinicians differentiate between these tumors ante mortem to guide appropriate treatment and intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urologic Surgery, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
- Veterans Affairs (VA)-Northern California Healthcare System, Mather, CA 95655, USA.
- Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95718, USA.
ORCID-Profile: Demitria M Vasilatis, Paramita M Ghosh
Förderung
- NIH HHS
- training fellowship NIH
Zitieren
APA
Vasilatis, D. M., & Ghosh, P. M. (2024). Clinicopathologic Characterization of Prostatic Cancer in Dogs. Animals, 14(4), 588. https://doi.org/10.3390/ani14040588
Vancouver
Vasilatis DM, Ghosh PM. Clinicopathologic Characterization of Prostatic Cancer in Dogs. Animals. 2024;14(4):588. doi:10.3390/ani14040588
BibTeX
@article{Vasilatis2024,
author = {Vasilatis, Demitria M and Ghosh, Paramita M},
title = {Clinicopathologic Characterization of Prostatic Cancer in Dogs},
journal = {Animals},
year = {2024},
volume = {14},
number = {4},
pages = {588},
doi = {10.3390/ani14040588}
}
EUVIMED